For many Boards of Directors, compliance reporting feels familiar and reassuring. Dashboards are green. Policies are updated.
BOSTON, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (SNSE), a clinical-stage biotechnology company focused on the discovery and development of next-generation therapeutics for ...